Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2014; 04(03): 070-074
DOI: 10.1055/s-0040-1703805
Original Article

THE TLINICAL EFFICACY OF AUTOLOGOUS CONCENTRATED PLATELETS IN TREATMENT OF TMJ DISORDERS - A PILOT STUDY

S.M. Sharma
1   Head of the Department, Department of Oral and Maxillofacial Surgery A.B. Shetty Memorial Institute of Dental Sciences, Nitte University, Mangalore - 575 018 Karnataka, India.
,
Dhruvit Thakar
2   Junior Resident, Department of Oral and Maxillofacial Surgery A.B. Shetty Memorial Institute of Dental Sciences, Nitte University, Mangalore - 575 018 Karnataka, India.
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

Platelet rich plasma is a natural concentrate of autologous blood growth factor which is obtained by sequestering and concentrating platelets by gradient density centrifugation experimented in different fields of medicine in order to test its potential to enhance tissue regeneration. These platelets when activated undergo degranulation to release growth factors with healing properties. It also contains plasma, cytokines, thrombin, and other growth factors that are implicated in wound healing and have inherent biological and adhesive properties. The aim of the study is to explore a novel approach to treat degenerative lesion of the articular cartilage of temporomandibular joint. Patients with chronic degenerative conditions of the joint, were treated with intra articular PRP injections. The procedure involved collection of 10 ml of venous blood and twice centrifuged to obtain 2 ml of PRP which was used for injection after activation by calcium chloride. The patients were clinically prospectively evaluated before and at the end of the treatment, and at 2, 4, and 6 months of follow up. Inter incisical mouth opening, clicking of temporomandibular joint and VAS for pain were used for clinical evaluation. The results showed significant improvement of all clinical scores from basal evaluation to the end of the therapy and on follow up at 2-6 months. The preliminary results indicate that the treatment with PRP injections are safe and has the potential to reduce pain and improvement joint function with low degree of articular degeneration.

Keywords

PRP-Articular Cartilage-Temporomandibular Joint-Intra Articular Injections.


Publication History

Article published online:
26 April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poeling GG (1997) Cartilage injury: a review of 31, 516 knee arthroscopies. Arthroscopies 13:456-460
  • 2 Alford JW, Cole BJ (2005) Cartilage restoration, part I: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med 33:295-306
  • 3 Buckwalter JA, Brown TD (2004) Joint injury, repair, and remodelling: roles in post-traumatic osteoarthritis. Clin Orthop Relat Res 427:7-16
  • 4 Ochi M, Ucho Y, Kawasaki K, Wakitani S, Iwasa J(2002) Transplantation of cartilage-like tissue made by tissue engineering in treatment of cartilage defects of knee. J Bone Joint Surg Br 84:571-578
  • 5 Sgaglione NA, Miniaci A, Gillogly SD, Carter TR (2002) Update on advanced surgical techniques in treatment of traumatic focal articular cartilage lesion in the knee. Arthroscopy 18:9-32
  • 6 Hayami T (2008) Osteoarthritis of knee joint as a cause of musculoskeletal ambulation disability symptom complex (MADS). Clin Calcium 18:1574-1580
  • 7 Ulrich-Vinther M, Maloney MD, Schwarz EM, Rosier R, O'Keefe RJ (2003) Articular cartilage biology. J Am Acad Orthop Surg 11:421-430
  • 8 Fazer A, Bunning RA, Thavarajah M, Seid JM, Russell RG (1994) Studies on type II collegen and aggercan production in human articular chondrocytes in vitro and effects of tranforming growth factor-beta and interlukin-1beta. Osteoarthr cartil 2:235-245
  • 9 Grimaud E, Heymann D, Redini F (2002) Recent advance in TGF-beta effect on chondrocyte metabolism.Potential therpeutic roles of TGFbeta in cartilage disorder. Cytokine Growth Factor Rev 13:241-257
  • 10 Hickey DG, Frenkel SR, Di Cesare PE (2003) Clinical application of growth factor for articular cartilage repair. Am J Orthop 32:70-76
  • 11 Schmidt MB, Chen EH, Lynch SE (2006) A review of effects of insulinlike growth factors and platelet derived growth factors on in vivo cartilage healing and repair. Osteoarth Cartil 14:403-412
  • 12 Song SU, Hong YJ,Oh IS, Yi Y, Choi KB, Lee JW, Park KW,Han JU, SUJ JK, Lee KH (2004) Regenration of hyaline articular cartilage with irradiated transforming growth factor beta-1 producing fibroblast. Tissue Engg 10:665-672
  • 13 Anitua E. Plasma rich in growth factors: Preliminary result of use in preparation of future sites of implants. Int J Oral Maxillofac Implants 1999;14:529-535.
  • 14 Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substance: An in vitro study. J Bone Joint Surg Br 2007;89:417-420.
  • 15 Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of protein for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
  • 16 Asfaha S, Cenac N, Houle S, et al. Protease-activated receptor-4: aA novel mechanism of inflamatory pain modulation. Br J Pharmacol References: 2007;150:176-185
  • 17 Elizaveta Kon, Robert Buda, Gluseppe Filardo et al. Platelets-Rich Plasma: Intra-articular Knee Injections produced favorable results on degenerative cartilage lesion. Knee surg sports traumatol arthsoc octo 2009;1-8.
  • 18 Murakami KL, Iizuka T, Matsuki M, et al. Recapturing the persistently anteriorly displaced disk by mandibular manipulation after pumping and hydraulic pressure to the upper joint cavity of temporomandibular joint. Cranio 1987;5(1):17-24.
  • 19 O' Keefe RJ, Crabb ID, Puzas JE, Rosier RN(1994). Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin like growth factor-1. J Orthop Res 12;299-310.
  • 20 Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, Galera P, Boumediene K (2008). Interleukin-1 and transforming growth factor beta-1 as crucial factors in osseoarthritic cartilage metabolism. Connect tissue Res 49:293-297.
  • 21 Song SU, Cha YD, Han JU, Oh IS, Choi KB, Lee JW et al(2005) Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor beta-1 producing chondrocytes. Tissue Eng 11:1516-1526.
  • 22 Noth U, Rackwitz L, Heymer A, Weber M, Baumann B, Steinert A et al (2007). Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogel. J Biomed Mater Res A 83:626-635.
  • 23 Schmidt MB, Chen EH, Lynch SE (2006). A review of effects of insulin like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Ostoarthr Cartil 14:403-412.
  • 24 Martin JA, Buckwalter JA (2000) The role of chondrocyte-matrix interaction in maintaining and repairing articular cartilage. Biorheology 37:129-140.
  • 25 Sanchez M, Sheridan P, Kupp L (2003) Is platelet rich plasma a perfect enhancement factor? A current review. Int J Oral and Maxillofac Implants 18:93-103.
  • 26 Frisbie DD, Kawcak CE, Werpy NM, Park RD, Mcllwraith CW (2007) Clinical, biochemical, and histological effects of intra articular administered of autologous conditioned serumin horses with experimentally induced osteoarthritis.
  • 27 Gaissmaier C, Fritz J, Krachhardt T, Flesch I, Aicher WK, Ashammakhi N (2005) Effect Of platelet rich supernatant on proliferation and matrix synthesis of human articular chondrocyte in monolayer and three dimensional alginate cultures. Biomaterial 26:1953-1960.
  • 28 Saito M, Takahashi KA, Arai Y, Inoue A, Sakao K, Tonomura H, Honjo K, Nakagawa S et al. (2009) Intraarticular administration of platelet rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in rabbit knee. Clin Exp Rheumatol 27:201-207.